← All trials
NCT00749307
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jun 1, 2008
- Primary completion
- Sep 1, 2009
- Completion date
- Nov 1, 2009
- First posted
- —
- Last posted
- —
- Enrollment
- 50
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Campus Bio-Medico UniversityLead sponsor
- Campus Bio-Medico UniversityOverall official - principal investigator
- Campus Bio-Medico UniversityStudy director
- Vita-Salute University of Milano. ItalyCollaborator
- Pharmanutra s.r.l.Collaborator
- DSMCollaborator
- Vita-Salute University of Milano. ItalyOverall official - principal investigator
- Vita-Salute University of Milano. ItalyStudy director
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.